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Primary cutaneous CD8+ small/medium-sized pleomor-
phic T-cell lymphoma (CD8+ SMPTL) is a rare entity 
with most probably indolent clinical behaviour. Several 
cases with facial localisation, mostly localised to the ear, 
have previously been described (1). Reports of extrafacial 
involvement are limited, and mostly involve acral sites 
such as the hands and feet. The classification concerning 
this rare cutaneous lymphoma remains to be defined. To 
date, no treatment modalities have been systematically 
evaluated.
CASE REPORT
We report a case of a 54-year-old man with dissemi-
nated CD8+ SMPTL and excellent treatment response 
to hydroxychloroquine. The disease initially presented 
in 2010 with several erythematous papules and small 
nodules localised on the left foot which were treated 
successfully with low dose soft X-ray irradiation (32 
Gy using 100 kV) (2). Staging was negative for ex-
tracutaneous involvement. About 5 months after the 
initial presentation, the disease progressed slowly with 
the development of multiple brownish-reddish nodules 
disseminated on the whole body surface area, most ac-
centuated on the trunk. Routine PCR diagnostic proce-
dure revealed monoclonal rearrangement of the T-cell 
receptor, and immunohistochemical analysis revealed 
positivity for CD8 and TIA1 (Fig. 1). Interestingly, 
the bystander inflammatory infiltrate was dominated 
by CD68+ histiocytes, which accounted for an unusual 
granulomatous-like histological appearance of the 
lesions (Fig. 1). This fact, as well as 3 relapses after 
low-dose X-ray radiotherapy and intralesional steroid 
application, motivated us for a therapeutic approach 
with low dose systemic corticosteroids (7.5 mg pred-
nisolone daily) and hydroxychloroquine (400 mg/day), 
which resulted in immediate clinical improvement of 
the lesions (Fig. 2).
DISCUSSION
The patient’s history was positive for X-linked agam-
maglobulinemia (XLA; i.e. Bruton agammaglobuline-
mia), a primary inherited immunodeficiency syndrome 
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Fig. 1. Primary cutaneous CD8+ small/medium-sized pleomorphic T-cell lymphoma. 
A well demarcated, non epidermotropic infiltrate composed of small- to medium-sized pleomorphic lymphocytes. The neoplastic cells coexpress CD8 
and the cytotoxic granule-associated RNA binding protein TIA1. Note the marked predominance of CD68 positive histiocytes in the infiltrate. H&E: 
hematoxylin and eosin staining; CD:  cluster of differentiation.
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with insufficiency of B-cell antibody production caused 
by mutations in the gene coding for Bruton tyrosine 
kinase (BTK). He had been on intravenous immunoglo-
bulin replacement since XLA was first diagnosed at 
age 17, and had a history of chronic sinusitis as well 
as chronic obstructive pneumopathy. Furthermore, he 
was on low dose methotrexate for treatment of sero-
negative polyarthritis. 
In general, patients with antibody deficiencies seem 
at higher risk to develop haematological malignan-
cies, including cutaneous lymphoma. However, these 
malignancies are predominantly of B-cell origin (3). 
The correlation of primary cutaneous peripheral T-cell 
lymphoma, especially CD8+ SMPTL, and XLA is still 
elusive. One recent case report from Park et al. (4) 
describes a primary cutaneous T-cell lymphoma, not 
otherwise specified in a patient with XLA. In 2001, 
Kanavaros et al. (5) reported of an extranodal cytotoxic 
T-cell lymphoma in another patient with XLA. There 
are no previously documented cases of CD8+ SMPTL 
in XLA. Assumptions of pathogenesis include, but are 
not limited to, antigen overstimulation through chronic 
infections in an immunodeficient setting. This may ex-
plain, to a certain extent, the granulomatous type of the 
bystander tumour inflammation, as seen in our patient.
There is no standard treatment for CD8+ SMPTL, and 
current treatment options are limited. Hydroxychloro-
quine is an unusual treatment for cutaneous lymphoma, 
which proved extremely effective in this patient.
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Fig. 2. Clinical and positron emission tomography findings before start of treatment (A) and after 9 months of treatment with low dose systemic 
corticosteroids and hydroxychloroquine (Tx) (B).
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